Abalos Therapeutics

OverviewSuggest Edit

Abalos Therapeutics is a company that develops immune virotherapy against cancer. It provides Fast Evolution platform that helps to eliminate the malignant tumor tissue. 

    TypePrivate
    Founded2019
    Websiteabalos-tx.com

    Latest Updates

    Employees (est.) (Feb 2020)7(+17%)

    Key People/Management at Abalos Therapeutics

    Marcus Kostka

    Marcus Kostka

    CEO
    Jörg Vollmer

    Jörg Vollmer

    CSO
    Thomas Raueiser

    Thomas Raueiser

    Board Member
    Show more

    Abalos Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2019

    Abalos Therapeutics total Funding

    $13.2 m

    Abalos Therapeutics latest funding size

    $13.23 m

    Time since last funding

    4 months ago

    Abalos Therapeutics investors

    Abalos Therapeutics's latest funding round in October 2019 was reported to be $13.2 m. In total, Abalos Therapeutics has raised $13.2 m
    Show all financial metrics

    Abalos Therapeutics Online and Social Media Presence

    Embed Graph

    Abalos Therapeutics Frequently Asked Questions

    • When was Abalos Therapeutics founded?

      Abalos Therapeutics was founded in 2019.

    • Who are Abalos Therapeutics key executives?

      Abalos Therapeutics's key executives are Marcus Kostka, Jörg Vollmer and Thomas Raueiser.

    • How many employees does Abalos Therapeutics have?

      Abalos Therapeutics has 7 employees.